Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

Share

Norwegian Pharma AS

Closing information (x1000 SEK)

Closing information 2022/12 2021/12 2020/12
Turnover 11,483 More Arrow 11,686 More Arrow 15,151
Financial expenses 44 More Arrow 52 More Arrow 112
Earnings before taxes 2,138 More Arrow 2,428 More Arrow 4,641
Total assets 7,273 More Arrow 9,286 More Arrow 12,769
Current assets 7,273 More Arrow 9,286 More Arrow 12,769
Current liabilities 1,913 Less Arrow 1,598 More Arrow 1,647
Equity capital 5,360 More Arrow 7,686 More Arrow 11,123
- share capital 106 Less Arrow 103 Less Arrow 95

Financial ratios

Fiscal year 2022/12 2021/12 2020/12
Solvency 73.7% More Arrow 82.8% More Arrow 87.1%
Turnover per employee
Profit as a percentage of turnover 18.6% More Arrow 20.8% More Arrow 30.6%
Return on assets (ROA) 30.0% Less Arrow 26.7% More Arrow 37.2%
Current ratio 380.2% More Arrow 581.1% More Arrow 775.3%
Return on equity (ROE) 39.9% Less Arrow 31.6% More Arrow 41.7%
Change turnover -565 Less Arrow -4,590 More Arrow 271
Change turnover % -5% Less Arrow -28% More Arrow 2%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2022/12 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.